These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31494260)

  • 1. Quality assurance for genotyping and resistance testing of Clostridium (Clostridioides) difficile isolates - Experiences from the first inter-laboratory ring trial in four German speaking countries.
    Berger FK; Mellmann A; von Müller L; Bischoff M; Gärtner BC;
    Anaerobe; 2020 Feb; 61():102093. PubMed ID: 31494260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nationwide study of molecular epidemiology and antimicrobial susceptibility of Clostridioides difficile in South Korea.
    Byun JH; Kim H; Kim JL; Kim D; Jeong SH; Shin JH; Kim YA; Shin JH; Shin KS; Uh Y
    Anaerobe; 2019 Dec; 60():102106. PubMed ID: 31655214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization, toxin detection and resistance testing of human clinical Clostridium difficile isolates from Lebanon.
    Berger FK; Rasheed SS; Araj GF; Mahfouz R; Rimmani HH; Karaoui WR; Sharara AI; Dbaibo G; Becker SL; von Müller L; Bischoff M; Matar GM; Gärtner B
    Int J Med Microbiol; 2018 Apr; 308(3):358-363. PubMed ID: 29478838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The recognition and characterisation of Finnish Clostridium difficile isolates resembling PCR-ribotype 027.
    Krutova M; Nyc O; Matejkova J; Kuijper EJ; Jalava J; Mentula S
    J Microbiol Immunol Infect; 2018 Jun; 51(3):344-351. PubMed ID: 28583353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Clostridium (Clostridioides) difficile PCR-Ribotype Distribution and Antimicrobial Resistance in a German Tertiary Care Hospital Over the Last 10 Years.
    Piepenbrock E; Stelzer Y; Berger F; Jazmati N
    Curr Microbiol; 2019 Apr; 76(4):520-526. PubMed ID: 30805700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in molecular epidemiology and antimicrobial resistance profiles of Clostridioides (Clostridium) difficile strains in the United States between 2011 and 2017.
    Tickler IA; Obradovich AE; Goering RV; Fang FC; Tenover FC;
    Anaerobe; 2019 Dec; 60():102050. PubMed ID: 31173889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change in antimicrobial susceptibility and PCR ribotypes of Clostridioides difficile in a hospital over 5 years: Correlation analysis with antimicrobial consumption.
    Seo MR; Kim B; Kim J; Pai H
    Int J Antimicrob Agents; 2019 Aug; 54(2):154-158. PubMed ID: 31173866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of a Clostridioides difficile sentinel surveillance system in Germany: First insights for 2019-2021.
    Abdrabou AMM; Bischoff M; Mellmann A; von Müller L; Margardt L; Gärtner BC; Berger FK;
    Anaerobe; 2022 Oct; 77():102548. PubMed ID: 35307546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011-2014.
    Freeman J; Vernon J; Pilling S; Morris K; Nicholson S; Shearman S; Longshaw C; Wilcox MH;
    Clin Microbiol Infect; 2018 Jul; 24(7):724-731. PubMed ID: 29066403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emergence of Clostridium difficile PCR ribotype 078 in piglets in the Czech Republic clusters with Clostridium difficile PCR ribotype 078 isolates from Germany, Japan and Taiwan.
    Krutova M; Zouharova M; Matejkova J; Tkadlec J; Krejčí J; Faldyna M; Nyc O; Bernardy J
    Int J Med Microbiol; 2018 Oct; 308(7):770-775. PubMed ID: 29859665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First genotypic characterization of toxigenic Clostridioides difficile in Lithuanian hospitals reveals the prevalence of the hypervirulent ribotype 027/ST1.
    Tratulyte S; Miciuleviciene J; Kuisiene N
    Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1953-1959. PubMed ID: 31327067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of toxin gene diversity, molecular epidemiology, and antimicrobial resistance of Clostridium difficile isolated from 12 hospitals in South Korea.
    Kim H; Jeong SH; Roh KH; Hong SG; Kim JW; Shin MG; Kim MN; Shin HB; Uh Y; Lee H; Lee K
    Korean J Lab Med; 2010 Oct; 30(5):491-7. PubMed ID: 20890081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High in vitro activity of fidaxomicin against Clostridium difficile isolates from a university teaching hospital in China.
    Cheng JW; Yang QW; Xiao M; Yu SY; Zhou ML; Kudinha T; Kong F; Liao JW; Xu YC
    J Microbiol Immunol Infect; 2018 Jun; 51(3):411-416. PubMed ID: 28693926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial activity of LFF571 and three treatment agents against Clostridium difficile isolates collected for a pan-European survey in 2008: clinical and therapeutic implications.
    Debast SB; Bauer MP; Sanders IM; Wilcox MH; Kuijper EJ;
    J Antimicrob Chemother; 2013 Jun; 68(6):1305-11. PubMed ID: 23420839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic resistance of clinical isolates of Clostridioides difficile in China and its association with geographical regions and patient age.
    Li H; Li WG; Zhang WZ; Yu SB; Liu ZJ; Zhang X; Wu Y; Lu JX
    Anaerobe; 2019 Dec; 60():102094. PubMed ID: 31499177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial resistance in large clostridial toxin-negative, binary toxin-positive Clostridium difficile ribotypes.
    Androga GO; Knight DR; Lim SC; Foster NF; Riley TV
    Anaerobe; 2018 Dec; 54():55-60. PubMed ID: 30053486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospital outbreak due to Clostridium difficile ribotype 018 (RT018) in Southern Germany.
    Berger FK; Gfrörer S; Becker SL; Baldan R; Cirillo DM; Frentrup M; Steglich M; Engling P; Nübel U; Mellmann A; Bischoff M; Gärtner B; von Müller L
    Int J Med Microbiol; 2019; 309(3-4):189-193. PubMed ID: 30879971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance for antimicrobial resistance in Australian isolates of Clostridium difficile, 2013-14.
    Knight DR; Giglio S; Huntington PG; Korman TM; Kotsanas D; Moore CV; Paterson DL; Prendergast L; Huber CA; Robson J; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV
    J Antimicrob Chemother; 2015 Nov; 70(11):2992-9. PubMed ID: 26221017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two Clusters of Fluoroquinolone and Clindamycin-Resistant Clostridium difficile PCR Ribotype 001 Strain Recognized by Capillary Electrophoresis Ribotyping and Multilocus Variable Tandem Repeat Analysis.
    Nyc O; Tejkalova R; Kriz Z; Ruzicka F; Kubicek L; Matejkova J; Kuijper E; Krutova M
    Microb Drug Resist; 2017 Jul; 23(5):609-615. PubMed ID: 27860531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic resistance patterns and PCR-ribotyping of Clostridium difficile strains isolated from swine and dogs in Italy.
    Spigaglia P; Drigo I; Barbanti F; Mastrantonio P; Bano L; Bacchin C; Puiatti C; Tonon E; Berto G; Agnoletti F
    Anaerobe; 2015 Feb; 31():42-6. PubMed ID: 25316022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.